Deficiency of carboxylesterase 1/esterase-x results in obesity, hepatic steatosis, and hyperlipidemia

Hepatology

Volumn 56, Issue 6, 2012, Pages 2188-2198

  Quiroga, Ariel D ^a   Li, Lena ^a   Trötzmüller, Martin ^b   Nelson, Randy ^a   Proctor, Spencer D ^a   Köfeler, Harald ^b   Lehner, Richard ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CARBOXYLESTERASE; CARBOXYLESTERASE 1; ESTERASE; ESTERASE X; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; ENERGY EXPENDITURE; ENERGY METABOLISM; FATTY LIVER; FEMALE; FOOD INTAKE; HOMEOSTASIS; HYPERINSULINEMIA; HYPERLIPIDEMIA; INSULIN SENSITIVITY; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; MOUSE; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD GLUCOSE; CARBOXYLIC ESTER HYDROLASES; CHOLESTEROL; DOCOSAHEXAENOIC ACIDS; ENERGY METABOLISM; FASTING; FATTY ACIDS, UNSATURATED; FATTY LIVER; FEMALE; FISH OILS; GENE EXPRESSION; HEPATOCYTES; HYPERLIPIDEMIAS; INSULIN; LIPOPROTEINS, VLDL; MICE; MICE, KNOCKOUT; OBESITY; PHENOTYPE; PHOSPHOLIPIDS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIGLYCERIDES;

EID: 84868701222     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25961     Document Type: Article

References (22)

1. van den Berghe G. The role of the liver in metabolic homeostasis: implications for inborn errors of metabolism. J Inherit Metab Dis 1991; 14: 407-420.
2. Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 2004; 279: 32345-32353.
3. Sanyal AJ. Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 46-53.
4. Holmes RS, Wright MW, Laulederkind SJ, Cox LA, Hosokawa M, Imai T, et al. Recommended nomenclature for five mammalian carboxylesterase gene families: human, mouse, and rat genes and proteins. Mamm Genome 2010; 21: 427-441.
5. Gilham D, Ho S, Rasouli M, Martres P, Vance DE, Lehner R. Inhibitors of hepatic microsomal triacylglycerol hydrolase decrease very low density lipoprotein secretion. Faseb J 2003; 17: 1685-1687.
6. Wei E, Ben Ali Y, Lyon J, Wang H, Nelson R, Dolinsky VW, et al. Loss of TGH/Ces3 in mice decreases blood lipids, improves glucose tolerance, and increases energy expenditure. Cell Metab 2010; 11: 183-193.
7. Dolinsky VW, Gilham D, Alam M, Vance DE, Lehner R. Triacylglycerol hydrolase: role in intracellular lipid metabolism. Cell Mol Life Sci 2004; 61: 1633-1651.
8. Ellinghaus P, Seedorf U, Assmann G. Cloning and sequencing of a novel murine liver carboxylesterase cDNA. Biochim Biophys Acta 1998; 1397: 175-179.
9. Kennedy AR, Pissios P, Otu H, Roberson R, Xue B, Asakura K, et al. A high-fat, ketogenic diet induces a unique metabolic state in mice. Am J Physiol Endocrinol Metab 2007; 292: E1724-1739.
10. Flowers MT, Keller MP, Choi Y, Lan H, Kendziorski C, Ntambi JM, et al. Liver gene expression analysis reveals endoplasmic reticulum stress and metabolic dysfunction in SCD1-deficient mice fed a very low-fat diet. Physiol Genomics 2008; 33: 361-372.
11. Ko KW, Erickson B, Lehner R. Es-x/Ces1 prevents triacylglycerol accumulation in McArdle-RH7777 hepatocytes. Biochim Biophys Acta 2009; 1791: 1133-1143.
12. Azzout-Marniche D, Becard D, Guichard C, Foretz M, Ferre P, Foufelle F. Insulin effects on sterol regulatory-element-binding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes. Biochem J 2000; 350(Pt 2): 389-393.
13. Deng X, Cagen LM, Wilcox HG, Park EA, Raghow R, Elam MB. Regulation of the rat SREBP-1c promoter in primary rat hepatocytes. Biochem Biophys Res Commun 2002; 290: 256-262.
14. Jump DB, Botolin D, Wang Y, Xu J, Christian B, Demeure O. Fatty acid regulation of hepatic gene transcription. J Nutr 2005; 135: 2503-2506.
15. Xu J, Teran-Garcia M, Park JH, Nakamura MT, Clarke SD. Polyunsaturated fatty acids suppress hepatic sterol regulatory element-binding protein-1 expression by accelerating transcript decay. J Biol Chem 2001; 276: 9800-9807.
16. Fojo SS, Brewer HB. Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II. J Intern Med 1992; 231: 669-677.
17. Rensen PC, van Berkel TJ. Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo. J Biol Chem 1996; 271: 14791-14799.
18. Huang Y, Liu XQ, Rall SC Jr, Taylor JM, von Eckardstein A, Assmann G, et al. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. J Biol Chem 1998; 273: 26388-26393.
19. Bergman RN, Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab 2000; 11: 351-356.
20. Cho Y, Ariga M, Uchijima Y, Kimura K, Rho JY, Furuhata Y, et al. The novel roles of liver for compensation of insulin resistance in human growth hormone transgenic rats. Endocrinology 2006; 147: 5374-5384.
21. Hamann A, Flier JS, Lowell BB. Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemia. Endocrinology 1996; 137: 21-29.
22. Lowell BB, V SS, Hamann A, Lawitts JA, Himms-Hagen J, Boyer BB, et al. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 1993; 366: 740-742.